The life science industry is truly global, just like arbitration. Is resolving disputes in this field with arbitration therefore a good cure? During our side event against the backdrop of the Paris Arbitration Week we will explore the dispute needs of the life science industry from different perspectives.
Do the different players, from big pharma to biotechnological start-ups, have the same needs and do they resort to the same methods? What are the typical disputes in an innovation-driven and highly regulated industry where investment costs are massive, cooperation across borders common, protection of intellectual property rights critical and blockbuster opportunities globally scaled? What are the experiences with arbitrating life science disputes and what innovations are desired?
For further information, please refer to the programme. Participation in this event is free of charge.
This event takes place in the framework of Paris Arbitration Week 2026.
For further information and registration, please visit the event website.
Your DIS Team